JP2011513241A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513241A5
JP2011513241A5 JP2010547861A JP2010547861A JP2011513241A5 JP 2011513241 A5 JP2011513241 A5 JP 2011513241A5 JP 2010547861 A JP2010547861 A JP 2010547861A JP 2010547861 A JP2010547861 A JP 2010547861A JP 2011513241 A5 JP2011513241 A5 JP 2011513241A5
Authority
JP
Japan
Prior art keywords
phe
lys
arg
subject
dmt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010547861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513241A (ja
JP5677096B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/035132 external-priority patent/WO2009108695A2/en
Publication of JP2011513241A publication Critical patent/JP2011513241A/ja
Publication of JP2011513241A5 publication Critical patent/JP2011513241A5/ja
Application granted granted Critical
Publication of JP5677096B2 publication Critical patent/JP5677096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010547861A 2008-02-26 2009-02-25 急性腎障害を予防および治療するための方法 Active JP5677096B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3158508P 2008-02-26 2008-02-26
US61/031,585 2008-02-26
PCT/US2009/035132 WO2009108695A2 (en) 2008-02-26 2009-02-25 Methods for prevention and treatment of acute renal injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014263863A Division JP2015063561A (ja) 2008-02-26 2014-12-26 急性腎障害を予防および治療するための方法

Publications (3)

Publication Number Publication Date
JP2011513241A JP2011513241A (ja) 2011-04-28
JP2011513241A5 true JP2011513241A5 (enExample) 2012-04-12
JP5677096B2 JP5677096B2 (ja) 2015-02-25

Family

ID=41013650

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2010547861A Active JP5677096B2 (ja) 2008-02-26 2009-02-25 急性腎障害を予防および治療するための方法
JP2014263863A Pending JP2015063561A (ja) 2008-02-26 2014-12-26 急性腎障害を予防および治療するための方法
JP2016087350A Pending JP2016175924A (ja) 2008-02-26 2016-04-25 急性腎障害を予防および治療するための方法
JP2017179838A Pending JP2017226697A (ja) 2008-02-26 2017-09-20 急性腎障害を予防および治療するための方法
JP2018241524A Pending JP2019059785A (ja) 2008-02-26 2018-12-25 急性腎障害を予防および治療するための方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2014263863A Pending JP2015063561A (ja) 2008-02-26 2014-12-26 急性腎障害を予防および治療するための方法
JP2016087350A Pending JP2016175924A (ja) 2008-02-26 2016-04-25 急性腎障害を予防および治療するための方法
JP2017179838A Pending JP2017226697A (ja) 2008-02-26 2017-09-20 急性腎障害を予防および治療するための方法
JP2018241524A Pending JP2019059785A (ja) 2008-02-26 2018-12-25 急性腎障害を予防および治療するための方法

Country Status (7)

Country Link
US (9) US8143219B2 (enExample)
EP (3) EP2262520B1 (enExample)
JP (5) JP5677096B2 (enExample)
CN (4) CN106975070A (enExample)
DK (1) DK2262520T3 (enExample)
HK (1) HK1202429A1 (enExample)
WO (1) WO2009108695A2 (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200509229B (en) 2003-05-01 2007-03-28 Cornell Res Foundation Inc Method and carrier complexes for delivering molecules to cells
KR20150013353A (ko) 2005-09-16 2015-02-04 코넬 리서치 화운데이션,인크. Ｃｄ36 발현을 감소시키는 방법
WO2009108695A2 (en) 2008-02-26 2009-09-03 Cornell University Methods for prevention and treatment of acute renal injury
CN102573881A (zh) * 2009-03-20 2012-07-11 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法
JP5909182B2 (ja) * 2009-08-12 2016-04-26 コーネル ユニヴァーシティー 代謝性症候群を予防し又は治療するための方法
EP4302829B1 (en) * 2009-08-24 2025-05-21 Stealth BioTherapeutics Inc. Peptide for use in preventing or treating macular degeneration
EP3603658B1 (en) 2009-10-05 2025-01-08 Cornell University Peptide for use in the treatment of heart failure resulting from hypertrophic cardiomyopathy
JP2013516425A (ja) * 2009-12-31 2013-05-13 ステルス ペプチドズ インターナショナル インコーポレイテッド 血管閉塞傷害の予防または治療方法
JP2013516426A (ja) * 2009-12-31 2013-05-13 ステルス ペプチドズ インターナショナル インコーポレイテッド 冠状動脈バイパス移植術を行うための方法
EP2528934A4 (en) * 2010-01-25 2013-08-21 Univ Cornell AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
US8585597B2 (en) * 2010-03-12 2013-11-19 Sonogenix, Inc. Renal injury inhibiting devices, systems, and methods employing low-frequency ultrasound or other cyclical pressure energies
EP3375449A1 (en) 2010-03-15 2018-09-19 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
EP2566880A4 (en) * 2010-05-03 2014-10-08 Stealth Peptides Int Inc AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
AU2011352333B2 (en) * 2010-12-31 2016-12-08 Zeus Scientific, Inc. Improved methods for determining cell viability using molecular nucleic acid-based techniques
EP3488941A1 (en) * 2011-03-24 2019-05-29 Cornell University Aromatic-cationic peptides and uses of same
WO2012158518A1 (en) * 2011-05-13 2012-11-22 The Penn State Research Foundation Treatment of renal injury
CN103857407A (zh) * 2011-08-10 2014-06-11 迪格纳生物技术公司 心肌营养素-1治疗肾脏疾病的用途
WO2013049697A1 (en) 2011-09-29 2013-04-04 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
CN104114181B (zh) * 2011-10-17 2017-06-09 康奈尔大学 芳香族阳离子肽及其用途
US9353171B2 (en) 2011-11-17 2016-05-31 The Administrators Of The Tulane Educational Fund Use of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP analogs for treating contrast-induced nephropathy
EP3466439A1 (en) 2011-12-09 2019-04-10 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
EP3281634A1 (en) * 2012-02-22 2018-02-14 Stealth Peptides International, Inc. Method and compositions for preventing or treating ophthalmic conditions
US10808008B2 (en) * 2012-02-23 2020-10-20 Cornell University Aromatic-cationic peptides and uses of same
WO2013149172A1 (en) * 2012-03-30 2013-10-03 Stealth Peptides International, Inc. Methods and compositions for the prevention and treatment neuropathy
MX2015005102A (es) * 2012-10-22 2016-02-09 Stealth Peptides Int Inc Metodos para la reduccion de los riesgos asociados con el insuficiencia cardiaca y factores asociado con el mismo.
CA2916884C (en) * 2013-03-01 2021-02-09 Stealth Biotherapeutics Corp Methods for the treatment of mitochondrial disease
HUE046924T2 (hu) 2013-03-01 2020-03-30 Stealth Biotherapeutics Corp Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra
US10047395B2 (en) 2013-06-26 2018-08-14 Stealth Biotherapeutics Corp Methods and compositions for detecting and diagnosing diseases and conditions
US9895410B2 (en) 2013-12-12 2018-02-20 Cornell University Methods for preventing and treating oral cancers
WO2015153287A1 (en) * 2014-03-31 2015-10-08 Zoll Medical Corporation Blood filtering of inflammatory biomarkers to treat post-resuscitation syndrome
PL3160984T3 (pl) 2014-06-25 2021-10-25 Flamma S.P.A. Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylol- fenyloalaninoamidu
EP3160985B1 (en) 2014-06-30 2021-07-28 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
ES2870481T3 (es) 2014-08-21 2021-10-27 Stealth Biotherapeutics Corp Péptido D-Arg-2’,6’-Dmt-Lys-Phe-NH2 para el tratamiento del síndrome de Alport
US10870678B2 (en) 2016-04-11 2020-12-22 Arcuate Therapeutics, Inc. Chiral peptides
SG11201809982RA (en) * 2016-05-09 2018-12-28 Us Health Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents
CN107644976B (zh) * 2016-07-22 2020-09-29 清华大学 锂离子电池电极
US20180140599A1 (en) 2016-11-21 2018-05-24 Saghmos Therapeutics, Inc. Prevention and/or treatment of contrast-induced acute kidney injury
EP3692032B1 (en) 2017-10-03 2024-06-19 The U.S.A. as represented by the Secretary, Department of Health and Human Services Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents
IL276653B2 (en) 2018-02-22 2024-11-01 Us Health Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
WO2020018381A1 (en) 2018-07-18 2020-01-23 The Regents Of The University Of California Kidney injury treatment
CN109946139A (zh) * 2019-02-28 2019-06-28 东南大学 一种石蜡切片免疫组化套染pas试剂盒及其染色方法和应用
CN111686239B (zh) * 2019-03-11 2021-12-24 中国科学院微生物研究所 抗真菌化合物的应用
WO2020214518A1 (en) * 2019-04-18 2020-10-22 Arcuate Therapeutics, Inc. Methods of treating renal conditions using peptides that improve mitochondrial function
CN110250110A (zh) * 2019-07-11 2019-09-20 南京医科大学附属逸夫医院 一种顺铂所致急性肾损伤的小鼠模型的构建方法
EP3771467A1 (en) * 2019-07-30 2021-02-03 Fundacio Institut de Recerca de l'Hospital de la Santa Creu i sant Pau Ss-31 for the prevention and/or treatment of aneurysm
CN113209294B (zh) * 2020-02-05 2023-06-13 复旦大学 Dor激动剂在制备对抗肾脏纤维化药物中的应用
CN111419860A (zh) * 2020-03-19 2020-07-17 长春市儿童医院 一种肾小球分叶状肾病造模方法
KR102308991B1 (ko) 2020-04-08 2021-10-06 압타바이오 주식회사 조영제 유발 급성 신부전 치료제
MX2022012472A (es) 2020-04-08 2022-12-15 Aptabio Therapeutics Inc Agente para el tratamiento de lesion renal aguda inducida por medio de contraste.
CN111933006B (zh) * 2020-07-30 2022-06-03 四川大学华西医院 一种模拟巨噬细胞改善小鼠急性肾损伤实验的方法及系统
EP4210695A4 (en) 2020-09-09 2025-04-16 Social Profit Network Methods and compositions for delivery of biotin to mitochondria
US20220079984A1 (en) * 2020-09-11 2022-03-17 Renibus Therapeutics, Inc. Method for treating cancer with kidney protection
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5602100A (en) 1988-06-30 1997-02-11 Astra Ab Dermorphin analogs having pharmacological activity
ES2085865T3 (es) 1988-06-30 1996-06-16 Astra Ab Analogos de dermorfina, sus metodos de preparacion, composiciones farmaceuticas, y metodos de tratamiento terapeutico que los emplean.
US5652122A (en) 1989-12-21 1997-07-29 Frankel; Alan Nucleic acids encoding and methods of making tat-derived transport polypeptides
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5716644A (en) 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5674534A (en) 1992-06-11 1997-10-07 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
IS4261A (is) 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
DE69630918T2 (de) 1995-06-09 2004-10-28 Hisamitsu Pharmaceutical Co., Inc., Tosu Matrix für Iontophorese
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
AU1818299A (en) 1997-12-10 1999-06-28 Washington University Anti-pathogen system and methods of use thereof
US6268398B1 (en) 1998-04-24 2001-07-31 Mitokor Compounds and methods for treating mitochondria-associated diseases
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
SE9900961D0 (sv) 1999-03-16 1999-03-16 Astra Ab Novel compounds
CA2386239A1 (en) 1999-10-04 2001-04-12 University Of Medicine And Dentistry Of New Jersey Methods for identifying rna binding compounds
US6759520B1 (en) 1999-10-28 2004-07-06 The New England Medical Center Hospitals, Inc. Chimeric analgesic peptides
US20050192215A1 (en) 2000-01-21 2005-09-01 Malabika Ghosh Methods and materials relating to novel polypeptides and polynucleotides
JP2004502644A (ja) 2000-03-09 2004-01-29 ジェンザイム、コーポレーション 腎機能の喪失を治療または予防するためのＴＧＦ−β拮抗薬の使用
AU2001277908A1 (en) 2000-07-18 2002-01-30 Cornell Research Foundation Inc. Medicinal uses of mu-opioid receptor agonists
US6900178B2 (en) 2000-09-12 2005-05-31 University Of Kentucky Research Foundation Protection against ischemia and reperfusion injury
JP2004525955A (ja) 2001-04-05 2004-08-26 コッラジェネックス ファーマシューチカルス インコーポレイテッド テトラサイクリン化合物およびテトラサイクリン誘導体の制御された伝達
US20070015146A1 (en) 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
PT1599216E (pt) 2003-02-04 2013-12-17 Cornell Res Foundation Inc Métodos de prevenção da transição de permeabilidade mitocondrial
ZA200509229B (en) 2003-05-01 2007-03-28 Cornell Res Foundation Inc Method and carrier complexes for delivering molecules to cells
WO2005032481A2 (en) 2003-09-30 2005-04-14 Scios Inc. Quinazoline derivatives as medicaments
NZ549393A (en) * 2004-01-23 2009-07-31 Cornell Res Foundation Inc Methods for reducing oxidative damage
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
KR20150013353A (ko) 2005-09-16 2015-02-04 코넬 리서치 화운데이션,인크. Ｃｄ36 발현을 감소시키는 방법
US20080027082A1 (en) * 2006-06-19 2008-01-31 Berthold Hocher Use of adenosine a1 antagonists in radiocontrast media induced nephropathy
WO2009108695A2 (en) * 2008-02-26 2009-09-03 Cornell University Methods for prevention and treatment of acute renal injury

Similar Documents

Publication Publication Date Title
JP2011513241A5 (enExample)
FIC20230040I1 (fi) Koostumus käsittäen: sedatsuridiinia tai tämän farmaseuttisesti hyväksyttävää suolaa; ja desitabiinia.
JP2013518057A5 (enExample)
JP2010534684A5 (enExample)
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
JP2012126742A5 (enExample)
FR16C1026I2 (fr) Inhibiteurs de la replication du virus de l'hepatite c
IL196461A0 (en) Aircraft engine inlet pivotable barrier filter
GB2439552B (en) Pipeline protection system
NO2016016I2 (no) Lesinurad, eller et farmasøytisk akseptabelt salt derav
EP2337569A4 (en) COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
IL196012A0 (en) Low-foaming preparations for crop protection
WO2008069917A3 (en) Novel cyclic peptides
BRPI0818479A2 (pt) proteção de documentos por meio de informações digitais de marca d'água
SE0802004L (sv) Avgasåtercirkulationssystem
EP1983047A4 (en) Novel viral vector
ITTO20090210A1 (it) Sistema di cattura di immagini, in particolare avente la funzione di mascheratura di aree in un'immagine registrata
EP2048232A4 (en) NON-REPLICATIVE PARAMYXOVIRIDAE VIRUS VECTOR
JP2013510169A5 (enExample)
AR072974A1 (es) Sintesis de acetato de glatiramer
EP2015766A4 (en) CYCLISED ALPHA CONOTOXIN PEPTIDES
FI20065657L (fi) Soodakattilan sulakourun puhdistin
IL194344A (en) Pharmaceutical compound having antidepressant effect including the h – glu – asp – gly – oh peptide
JP2010510994A5 (enExample)
EP2160505A4 (en) DRAIN PIPE MESH NETWORK